sales staffs, advertising media fee for product promotion, distribution fee paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of company’ s products in the
0.00 12.21 N/A 6.95% 0.00% Revenues from reduction of defaulted interest under the Court’s order 16.66 0.00 16.66 N/A 9.48% 0.00% Distribution costs (24.14 ) (26.13 ) (1.99 ) 7.62% (13.74%) (8.83
) % Revenue from sales and service 1,788.5 2,025.3 1,187.1 (236.8) (11.7) 601.4 50.7 Cost of sales and service 1,499.5 1,686.8 998.7 (187.3) (11.1) 500.8 50.1 Selling and distribution expenses 73.7 78.7 52.0
tariff and Ft 816.7 821.3 774.5 (5.7%) (5.2%) 2,314.6 2,402.5 3.8% FiT Premium 20.7 19.1 15.0 (21.5%) (27.5%) 68.6 53.7 (21.7%) Sales of electricity to Industrial Users (IU) 6.2 6.8 8.3 22.1% 33.9% 19.1
and Ft 774.5 793.1 895.9 13.0% 15.7% 2,402.5 2,540.2 5.7% FiT Premium 15.0 13.9 12.9 (7.2%) (14.0%) 53.7 41.4 (22.9%) Sales of electricity to Industrial Users (IU) 8.3 7.4 7.0 (5.4%) (15.7%) 21.9 23.7
real estate development and service business. The Company has developed premium housing projects in central business area to open up new business opportunities. Moreover, the opportunity in rental real
- Authorized 140.00 140.00 - - Issued and paid-up 140.00 100.00 40.00 40.00 Share premium 246.11 - 246.11 n.a. Retained earning Appropriated - legal reserve 5.09 5.09 - - Unappropriated 63.87 44.31 19.56 44.13
) % Share capital Registered 1,536.4 1,464.7 71.7 4.9 Share premium 808.2 736.5 71.7 9.7 Retained earnings – Unappropriated 1,623.2 1,692.0 (68.8) (4.1) Total shareholders' equity 4,123.3 4,053.3 70.0 1.7
promotion expenses, cost of newspaper distribution and strict cost control. Consolidated administrative expenses for the year ended 31 December 2017 was 226.5 million baht, decreased 15.7 percent or 42.1
Distribution Platform Business in order to focus on the business development strategy. For the Online Top-Up & Payment Business, the Company continually focuses on managing the kiosk location and adding new